270 results on '"Bois, John P."'
Search Results
2. Imaging of Cardiac Sarcoidosis: An Update and Future Aspects
3. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis
4. A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19
5. Arrhythmic manifestations and outcomes of definite and probable cardiac sarcoidosis
6. Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy
7. PET/MRI: 'Inflammation'
8. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging
9. SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI
10. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience
11. Clinical Response To TNF-α Inhibitor Therapy In The Management Of Cardiac Sarcoidosis
12. Effect of Corticosteroid Therapy in Patients With Cardiac Sarcoidosis on Frequency of Venous Thromboembolism
13. PET/MRI: “Inflammation”
14. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol
15. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association
16. Severe Hypertriglyceridemia in a Patient With Metabolic Syndrome and Psoriasis on Risankizumab-Rzaa.
17. Imaging and Quantification of Cardiac Sarcoidosis
18. Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction
19. Comparison of Photon-counting Detector and Energy-integrating Detector CT for Visual Estimation of Coronary Percent Luminal Stenosis
20. Harnessing PET Imaging for Prognostic Precision in Cardiac Sarcoidosis.
21. Syntactic Alignment is an Index of A?ective Alignment:An Information-Theoretical Study of Natural Dialogue
22. PET/CT Evaluation of Cardiac Sarcoidosis
23. Patient page-sarcoidosis imaging
24. Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation
25. Spectrum of Aortic Disease in the Giant Cell Arteritis Population
26. Is it time to reassess the role of myocardial metabolic modulation for the treatment of heart failure?
27. The impact of combined cardiopulmonary exercise testing and SPECT myocardial perfusion imaging on downstream evaluation and management
28. Detection of cardiac sarcoidosis with the artificial intelligence–enhanced electrocardiogram
29. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography
30. State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association
31. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy
32. CARDIAC SEQUELAE OF LONG-COVID
33. The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis
34. Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy
35. Radionuclide Imaging in Congestive Heart Failure: Assessment of Viability, Sarcoidosis, and Amyloidosis
36. Detection of Inflammatory Aortopathies Using Multimodality Imaging
37. Phase analysis single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) detects dyssynchrony in myocardial scar and increases specificity of MPI
38. Amyloid deposition in an explanted bioprosthetic aortic valve: case report and review of the literature
39. Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease
40. Cardiac resynchronization therapy response in cardiac sarcoidosis
41. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association
42. Benign lipomatous masses of the heart: a comprehensive series of 47 cases with cytogenetic evaluation
43. Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium–Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis
44. Abstract 20300: Microvascular Obstruction in Non Infarct Related Coronary Arteries in an Independent Predictor of Major Adverse Cardiovascular Events in ST Segment Elevation Myocardial Infarction Patients
45. Impact of acute left ventricular apical thrombus on cardioversion for atrial fibrillation
46. Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis†
47. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis.
48. Contemporary Advances in Myocardial Metabolic Imaging and Their Impact on Clinical Care: a Focus on Positron Emission Tomography (PET)
49. Utilization of cardiac imaging in sarcoidosis
50. PO-06-083 VENTRICULAR ARRHYTHMIC RISK IN CARDIAC SARCOIDOSIS PATIENTS WITH SYSTOLIC HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.